The Rising Influence of Rising Affluence

[DewDiligence]

AZN seeks steady growth in Africa:

http://www.bloomberg.com/news/articles/2016-02-10/astrazeneca-targets-africa-sales-boost-on-improved-health-care

AstraZeneca Plc, the U.K.’s second-largest drugmaker, plans to increase sales in Africa by almost 10 percent a year as the company seeks to capitalize on efforts by governments to improve health-care systems and fight conditions such as high blood pressure and cholesterol.

Construction is about to start on a manufacturing plant in Algeria costing “tens of millions of dollars... The factory will make drugs to treat cardiovascular disease, cancer and diabetes. AstraZeneca also has a plant in Egypt that manufactures drugs to lower blood pressure and cholesterol.

Africa’s pharmaceutical industry generated sales of $20.8 billion in 2013, compared with $4.7 billion a decade earlier, McKinsey and Co. said in June. The market may be worth as much as $65 billion by 2020…